{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:08:22Z","timestamp":1793178502580,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000402.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000}}],"reference-count":195,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000402.pub4","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T11:17:31Z","timestamp":1344424651000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Hormone therapy in postmenopausal women and risk of endometrial hyperplasia"],"prefix":"10.1002","volume":"2012","author":[{"given":"Susan","family":"Furness","sequence":"first","affiliation":[{"name":"School of Dentistry, The University of Manchester; Cochrane Oral Health Group; Coupland III Building, Oxford Rd Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Roberts","sequence":"additional","affiliation":[{"name":"University of Auckland; Obstetrics and Gynaecology; Private Bag 92019 Auckland New Zealand 1003"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Marjoribanks","sequence":"additional","affiliation":[{"name":"University of Auckland; Obstetrics and Gynaecology; Private Bag 92019 Auckland New Zealand 1003"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lethaby","sequence":"additional","affiliation":[{"name":"University of Auckland; Obstetrics and Gynaecology; Private Bag 92019 Auckland New Zealand 1003"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0015-0282(16)58690-7","article-title":"Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomised trial","volume":"66","author":"AinMelk","year":"1996","journal-title":"Fertility & Sterility"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/cmt.4.4.343.354","article-title":"Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate","volume":"4","author":"Al-Azzawi","year":"2001","journal-title":"Climacteric"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.gme.0000177318.24005.b1","article-title":"Long-term safety of drospirinone-estradiol for hormone therapy: a randomised, double-blind, multicenter trial","volume":"12","author":"Archer","year":"2005","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0004|cit4","unstructured":"Bouchard P Addo S Spielmann D The Trimegestone 301 Study Group A comparison of the effects of continuous combined regimens of 1mg 17B-estradiol and trimegestone with continuous combined estradiol and norethisterone acetate upon the bleeding profile and safety in postmenopausal women for up to 2 years Climacteric 2002 145"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09513590500168464","article-title":"Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol\/trimegestone versus 1 or 2 mg 17beta-estradiol\/norethisterone acetate in postmenopausal women","volume":"21","author":"Bouchard","year":"2005","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/09513590500128971","article-title":"Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate","volume":"21","author":"Gambacciani","year":"2005","journal-title":"Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0378-5122(01)00245-6","article-title":"Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study","volume":"40","author":"Bruhat","year":"2001","journal-title":"Maturitas"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub4-BIB0008|cit8","first-page":"523","article-title":"Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium","volume":"79","author":"Byrjalsen","year":"1992","journal-title":"Obstetrics & Gynecology"},{"issue":"Suppl","key":"10.1002\/14651858.CD000402.pub4-BIB0009|cit9","first-page":"19","article-title":"Progestational effects of combinations of gestodene on the postmenopausal endometrium during hormone replacement therapy","volume":"76","author":"Byrjalsen","year":"1997","journal-title":"Acta Obsterica et Gynecologica Scandinavica"},{"issue":"3 I","key":"10.1002\/14651858.CD000402.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0002-9378(99)70251-6","article-title":"Progestational effects of combinations of gestodene on the postmenopausal endometrium during hormone replacement therapy","volume":"180","author":"Byrjalsen","year":"1999","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1471-0528.2000.tb13230.x","article-title":"Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium","volume":"107","author":"Byrjalsen","year":"2000","journal-title":"BJOG: an International Journal of Obstetrics & Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00042192-200310020-00010","article-title":"Comparison of the difference in histopathology and cell cycle kinetics among the postmenopausal endometrium treated with different progestins in sequential-combined hormone replacement therapy","volume":"10","author":"Chang","year":"2003","journal-title":"Menopause"},{"issue":"7","key":"10.1002\/14651858.CD000402.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jama.1996.03540170041030","article-title":"The comparative effect on bone density, endometrium and lipids of continuous hormones as replacement therapy (CHART study). A randomised controlled trial","volume":"276","author":"Speroff","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0014|cit14","first-page":"279","article-title":"Effect of a unique constant estrogen, pulsed progestin hormone replacement therapy containing 17B estradiol and norgestimate on endometrial histology","volume":"44","author":"Corson","year":"1999","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0015|cit15","first-page":"286","article-title":"Efficacy and safety of constant estrogen, pulsed progestin regimen in hormone replacement therapy","volume":"44","author":"Sulak","year":"1999","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0002-9378(92)91653-R","article-title":"Low-dosage micronized 17B-estradiol prevents bone loss in postmenopausal women","volume":"166","author":"Ettinger","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/cmt.5.1.26.35","article-title":"Endometrial safety and bleeding patterns during a 2 year study of 1 or 2 mg of 17B-estradiol combined with sequential 5-20mg dydrogesterone","volume":"5","author":"Ferenczy","year":"2002","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0018|cit18","first-page":"398","article-title":"A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium","volume":"74","author":"Gelfand","year":"1989","journal-title":"Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697130009167612","article-title":"Comparison of the efficacy and endometrial safety of two estradiol valerate\/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women","volume":"3","author":"Graser","year":"2000","journal-title":"Climacteric"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.gme.0000184425.73567.12","article-title":"Oral hormone therapy with 17s-estradiol and 17s-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects","volume":"12","author":"Greenwald","year":"2005","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/archinte.1991.00400100060010","article-title":"The effects of estrone (OGEN) on spinal bone density of postmenopausal women","volume":"151","author":"Harris","year":"1991","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5122(96)01098-5","article-title":"HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women","volume":"26","author":"Heikkinen","year":"1997","journal-title":"Maturitas"},{"issue":"167","key":"10.1002\/14651858.CD000402.pub4-BIB0023|cit23","first-page":"P76.33","article-title":"Comparison of bleeding patterns and endometrial histology between a three monthly and monthly cycle HRT (abstract)","volume":"76","author":"Heikkinen","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica Supplement"},{"issue":"11","key":"10.1002\/14651858.CD000402.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s001980070031","article-title":"Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens","volume":"11","author":"Heikkinen","year":"2000","journal-title":"Osteoporosis International"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000402.pub4-BIB0025|cit25","first-page":"98","article-title":"Long-term endometrial safety of continuous combined HRT. Results from a 7-year randomised study","volume":"83","author":"Heikkinen","year":"2003","journal-title":"International Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Heikkinen J Vaheri R Timonen U A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: update of safety and quality-of-life findings [erratum appears in Journal of the British Menopause Society 2006;12(4):174] Journal of the British Menopause Society 2006 115 25","DOI":"10.1258\/136218006778234093"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1258\/1362180043654647","article-title":"Long-term safety and tolerability of continuous-combined hormone therapy in postmenopausal women: results from a seven-year randomised comparison of low and standard doses","volume":"10","author":"Heikkinen","year":"2004","journal-title":"Journal of the British Menopause Society"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1067\/mob.2000.104767","article-title":"Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a comparison of six different treatment regimens","volume":"182","author":"Heikkinen","year":"2000","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000402.pub4-BIB0029|cit29","first-page":"210","article-title":"Long-term data on endometrial safety and bleeding control with a continuous combined HRT regimen","volume":"5","author":"Weijer","year":"2002","journal-title":"Climacteric"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000402.pub4-BIB0030|cit30","first-page":"239","article-title":"Improved amenorrhoea, favourable vasomotor and lipid effects, and endometrial safety with lower doses of conjugated estrogens (CE) and medroxyprogesterone acetate (MPA)","volume":"14","author":"Archer","year":"2000","journal-title":"Gynecological Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(01)01792-7","article-title":"Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding","volume":"75","author":"Archer","year":"2001","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0015-0282(01)01828-3","article-title":"Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"76","author":"Pickar","year":"2001","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Pickar J Yeh I Wheeler J Cunnane M Speroff L Endometrial safety with lower doses of conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA) Fertility & Sterility 2001 52","DOI":"10.1016\/S0015-0282(01)02170-7"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0015-0282(03)01167-1","article-title":"Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results","volume":"80","author":"Pickar","year":"2003","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.GME.0000117062.54779.BD","article-title":"Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women","volume":"11","author":"Utian","year":"2004","journal-title":"Menopause"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"75","author":"Utian","year":"2001","journal-title":"Fertility & Sterility"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000402.pub4-BIB0037|cit37","first-page":"144","article-title":"A comparative 2-year study of two sequential regimens of 1mg estradiol and trimegestone with 1mg estradiol and norethisterone upon profiles of endometrial bleeding and safety in postmenopausal women","volume":"5","author":"Koninckx","year":"2002","journal-title":"Climacteric"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/09513590500168472","article-title":"A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women","volume":"21","author":"Koninckx","year":"2005","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/09513590500128815","article-title":"A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1mg 17 B-estradiol and trimegestone compared with a regimen containing 1mg estradiol valerate and norethisterone over a 2 year period","volume":"21","author":"Pornel","year":"2005","journal-title":"Gynaecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0040|cit40","first-page":"373","article-title":"Norethindrone acetate and estradiol-induced endometrial hyperplasia","volume":"96","author":"Kurman","year":"2000","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0041|cit41","first-page":"207","article-title":"Evaluation of low-dose estrogen and progestin therapy in postmenopausal women","volume":"38","author":"Luciano","year":"1993","journal-title":"Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13697130310001651481","article-title":"A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen","volume":"7","author":"Mattsson","year":"2004","journal-title":"Climacteric"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000402.pub4-BIB0043|cit43","first-page":"146","article-title":"Bleeding control, endometrial safety and tolerability of various continuous combined HRT regimens (abstract)","volume":"5","author":"Vaheri","year":"2002","journal-title":"Climacteric"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/gye.15.5.349.358","article-title":"A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone","volume":"15","author":"Meuwissen","year":"2001","journal-title":"Gynecological Endocrinology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000402.pub4-BIB0045|cit45","first-page":"120","article-title":"Effects of progestin dose and time since menopause on endometrial bleeding with continuous combine hormone replacement therapy","volume":"70","author":"Archer","year":"2000","journal-title":"International Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0046|cit46","first-page":"899","article-title":"Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding","volume":"96","author":"Archer","year":"2000","journal-title":"Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0047|cit47","first-page":"686","article-title":"Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate","volume":"83","author":"Archer","year":"1994","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0002-9378(97)70037-1","article-title":"Is bleeding a predictor of endometrial hyperplasia in postmenopausal women receiving hormone replacement therapy","volume":"177","author":"Pickar","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0002-9378(13)90437-3","article-title":"Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone","volume":"170","author":"Woodruff","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1479-828X.1995.tb01841.x","article-title":"Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy - a study of bleeding pattern, endometrial response, serum lipid and bone density changes","volume":"35","author":"Nand","year":"1995","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/archinte.1997.00440430091011","article-title":"Low-dose esterified estrogen therapy. Effects on bone, plasma estradiol concentrations, endometrium and lipid levels","volume":"157","author":"Genant","year":"1997","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"Lucas J Rebar R Speroff L Trabal J Silfen S A two-year study with low dose, continuous, unopposed esterified estrogens: prevention of postmenopausal bone loss with minimal endometrial effects Proceedings of the 8th International Congress on the Menopause, 1996, Nov 3-7 Sydney, Australia 1996 212","DOI":"10.1016\/S0378-5122(97)81499-5"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00042192-199704020-00004","article-title":"Minimal endometrial proliferation over a two-year period in postmenopausal women taking 0.3mg of unopposed esterified estrogens","volume":"4","author":"Notelovitz","year":"1997","journal-title":"Menopause"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0054|cit54","first-page":"130","article-title":"Low-dose unopposed estrogens: preliminary findings on the frequency and duration of vaginal bleeding in postmenopausal women receiving esterified estrogens over a two-year period","volume":"4","author":"Trabal","year":"1997","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0378-5122(93)90129-6","article-title":"A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment","volume":"16","author":"Obel","year":"1993","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0056|cit56","first-page":"678","article-title":"Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy","volume":"91","author":"Nand","year":"1998","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0057|cit57","doi-asserted-by":"crossref","unstructured":"Webster M Combination continuous therapy - what is the optimal MPA dose? Effect on bleeding profiles and endometrial histology Proceedings of the 8th International Congress on the Menopause, 1996 Nov 3-7 Sydney, Australia 1996 27","DOI":"10.1016\/S0378-5122(97)80918-8"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/humrep\/16.6.1244","article-title":"A prospective randomised controlled study comparing two doses of gestodene in cyclic combined HRT preparations on endometrial physiology","volume":"16","author":"Okon","year":"2001","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/eurheartj\/ehi695","article-title":"The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study","volume":"27","author":"Bots","year":"2006","journal-title":"European Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0197-2456(03)00096-5","article-title":"The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics","volume":"24","author":"Bots","year":"2003","journal-title":"Controlled Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.ajog.2006.03.045","article-title":"Effects of tibolone and continuous combined conjugated equine estrogen\/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study","volume":"195","author":"Langer","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1089\/15246090050118161","article-title":"Postmenopausal hormone use following a 3-year randomised clinical trial","volume":"9","author":"Barrett-Connor","year":"2000","journal-title":"Journal of Womens Health & Gender-Based Medicine"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/0197-2456(94)00119-N","article-title":"The Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial. Overview","volume":"16","author":"Bush","year":"1995","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/0197-2456(94)00033-Y","article-title":"Rationale, design, and conduct of the PEPI Trial","volume":"16","author":"Espeland","year":"1995","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1016\/0197-2456(94)00111-F","article-title":"Recruitment of postmenopausal women in the PEPI Trial","volume":"16","author":"Johnson","year":"1995","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0066|cit66","first-page":"853","article-title":"Bleeding patterns of the hormone replacement therapies in postmenopausal estrogen and progestin interventions trial","volume":"100","author":"Lindenfield","year":"2002","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"54S","DOI":"10.1016\/0197-2456(94)00113-H","article-title":"Baseline characteristics of the PEPI participants","volume":"16","author":"Miller","year":"1995","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1016\/0197-2456(95)96882-C","article-title":"Physical and laboratory measurements in the PEPI Trial","volume":"16","author":"Wood","year":"1995","journal-title":"Controlled Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial","volume":"275","author":"Writing Group for the Pepi trial","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0070|cit70","unstructured":"Portman DJ Shumel BS Symons JP Hormone replacement therapy (HRT) with 1 mg norethindrone acetate (NA) \/ 5 mcg ethinyl estradiol (EE) (FemHRT) provides greater protection against breakthrough bleeding versus 0.625 mg combined equine estrogens (CEE) \/ 2.5 mg medroxyprogesterone (MPA) (Prempro) The 3rd World Congress on Controversies in Obstetrics, Gynecology & Infertility 2002 82"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mob.2003.91","article-title":"A randomised, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone","volume":"188","author":"Portman","year":"2003","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD000402.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.290.8.1042","article-title":"Ultra-low-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial","volume":"290","author":"Prestwood","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13697130310001651445","article-title":"Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate\/medroxyprogesterone acetate therapy regimen","volume":"7","author":"Rees","year":"2004","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0020-7292(00)00342-8","article-title":"Constant estrogen, intermittent progestogen vs continuous combined hormone replacement: tolerability and effect on vasomotor symptoms","volume":"72","author":"Rozenberg","year":"2001","journal-title":"International Journal of Gynecology and Obstetrics"},{"issue":"Suppl","key":"10.1002\/14651858.CD000402.pub4-BIB0075|cit75","first-page":"S18","article-title":"One-year efficacy and safety of Prefect, a pulsed progestogen, constant estrogen hormone replacement therapy regimen","volume":"86","author":"Rozenberg","year":"1999","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0076|cit76","doi-asserted-by":"crossref","unstructured":"Ylikorkala O Lim P Caubel P Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol\/norethisterone acetate hormone replacement therapy Clinical Therapeutics 2000 622 36","DOI":"10.1016\/S0149-2918(00)80049-1"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1034\/j.1600-0412.2002.810712.x","article-title":"Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate","volume":"81","author":"Ylikorkala","year":"2002","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5122(99)00033-X","article-title":"Adverse endometrial effects during long cycle hormone replacement therapy","volume":"32","author":"Bjarnason","year":"1999","journal-title":"Maturitas"},{"issue":"10","key":"10.1002\/14651858.CD000402.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJM199603073341018","article-title":"Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy (letter)","volume":"334","author":"Cerin","year":"1996","journal-title":"New England of Journal of Medicine"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0080|cit80","doi-asserted-by":"crossref","unstructured":"Cerin A Hjarnason K Heldaas K Thomsen HK Boeller B Adverse endometrial effects during long cycle hormone replacement therapy Proceedings of the 8th International Congress on the Menopause, 1996, Nov 3-7 Sydney, Australia 1996 48","DOI":"10.1016\/S0378-5122(97)80981-4"},{"issue":"10","key":"10.1002\/14651858.CD000402.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-0528.1988.tb06511.x","article-title":"Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints","volume":"95","author":"Sporrong","year":"1988","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0378-5122(89)90212-0","article-title":"A novel statistical approach to analysis of bleeding patterns during continuous hormone replacement therapy","volume":"11","author":"Sporrong","year":"1989","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-5122(95)00949-3","article-title":"17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy","volume":"23","author":"Stadberg","year":"1996","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/13697139909025573","article-title":"Bleeding patterns and endometrial histology during administration of low-dose estradiol sequentially combined with dydrogesterone","volume":"2","author":"Weijer","year":"1999","journal-title":"Climacteric"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/13697130310001651535","article-title":"Safety and efficacy of drospirinone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis","volume":"7","author":"Warming","year":"2004","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0086|cit86","doi-asserted-by":"crossref","unstructured":"Anderson GL Judd HL Kaunitz AM Barad DH Beresford SAA Pettinger M Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.[see comment] JAMA 2003 1739 48","DOI":"10.1001\/jama.290.13.1739"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD000402.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/01.AOG.0000158120.47542.18","article-title":"Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative","volume":"105","author":"Barnabei","year":"2005","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","author":"Writing group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0089|cit89","first-page":"787","article-title":"Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement","volume":"84","author":"Williams","year":"1994","journal-title":"Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0090|cit90","first-page":"267","article-title":"Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis","volume":"37","author":"Wu","year":"2002","journal-title":"Chinese Journal of Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub4-BIB0091|cit91","first-page":"584","article-title":"A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin","volume":"116","author":"Xing","year":"2003","journal-title":"Chinese Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00404-005-0099-6","article-title":"Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding","volume":"273","author":"Yildirim","year":"2006","journal-title":"Archives of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0093|cit93","unstructured":"Aoki T Asai T Assessment of oestrogen replacement therapy with conjugated oestrogens by histological evaluation of the endometrium in 205 women Proceedings of the 6th International Congress on the Menopause, Bangkok, Thailand, 1990, Oct 29-Nov 3 Bangkok, Thailand 1990 151"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0094|cit94","first-page":"323","article-title":"Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate","volume":"94","author":"Archer","year":"1999","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(01)01792-7","article-title":"Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding","volume":"75","author":"Archer","year":"2001","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.maturitas.2003.08.013","article-title":"The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women","volume":"48","author":"Arrenbrecht","year":"2004","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0097|cit97","doi-asserted-by":"crossref","unstructured":"Bergeron C Nogales FF Rechberger T Tatarchjuk T Zipfel L Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17beta -oestradiol and 2.5mg dydrogesterone: protection of the endometrium and amenorrhoea rate Maturitas 2010 201 5","DOI":"10.3410\/f.2895956.2564054"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0098|cit98","first-page":"354","article-title":"Double-blind study of the effect of continuous therapy with estradiol valerate and medroxyprogesterone acetate on menopausal symptoms, lipid profile and endometrial thickness","volume":"59","author":"Blumel","year":"1994","journal-title":"Revista Chilena Obstetricia y Ginecologia"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-5122(92)90060-H","article-title":"Secretory endometrial protein PP14 in serum from post-menopausal women receiving continuous combined oestradiol-cyproterone acetate: correlation with serum hormone concentrations and bleeding patterns","volume":"15","author":"Byrjalsen","year":"1992","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0100|cit100","doi-asserted-by":"crossref","unstructured":"Byrjalsen I Thormann L Meinecke B Riis BJ Christiansen C Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy Human Reproduction 1992 1042 7","DOI":"10.1093\/oxfordjournals.humrep.a137791"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0306-3356(21)00374-5","article-title":"Oestrogen therapy and the menopausal syndrome","volume":"4","author":"Campbell","year":"1977","journal-title":"Clinics in Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0102|cit102","doi-asserted-by":"crossref","unstructured":"Campodonico I Valdivia I Bleeding pattern in two combined continuous hormone replacement therapy (HRT) regimes in climacteric women Proceedings of the 8th International Congress on the Menopause, 1996, Nov 3-7 Sydney, Australia 1996 191","DOI":"10.1016\/S0378-5122(97)81431-4"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/humrep\/14.Suppl_3.246","article-title":"Effects of cyclic continuous and sequential post-menopausal hormone replacement therapy on uterine bleeding and climacteric symptoms","volume":"14","author":"Chen","year":"1999","journal-title":"Human Reproduction"},{"issue":"8","key":"10.1002\/14651858.CD000402.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0002-9378(82)90176-4","article-title":"Dose-response evaluation of cyclic estrogen\/gestagen in postmenopausal women: placebo-controlled trial of its gynaecologic and metabolic actions","volume":"144","author":"Christensen","year":"1982","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0105|cit105","doi-asserted-by":"crossref","unstructured":"Endrikat J Graeser T Mellinger U Ertan K Holz C Endrikat J A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate\/2mg dienogest on hot flushes in postmenopausal women Maturitas 2007 201 7","DOI":"10.1016\/j.maturitas.2007.08.004"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-5122(02)00037-3","article-title":"The effects of oral estriol on the endometrium in postmenopausal women","volume":"42","author":"Granberg","year":"2002","journal-title":"Maturitas"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0107|cit107","first-page":"205","article-title":"The effect of different postmenopausal hormone replacement treatment protocols on endometrial thickness","volume":"46","author":"Gulhan","year":"2004","journal-title":"Gulhane Medical Journal"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/00016348209156564","article-title":"Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period","volume":"61","author":"Hagen","year":"1982","journal-title":"Acta Obstetrica et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0109|cit109","unstructured":"Heytmanek G Continuous hormone replacement therapy with oestradiol valerate alone and in combination with cyproterone acetate: clinical and endometrial findings Proceedings of the 6th International Congress on the Menopause, Bangkok, Thailand, 1990, Oct 29-Nov 3 Bangkok, Thailand 1990 86"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0110|cit110","doi-asserted-by":"crossref","unstructured":"Istre O Holm Nielsen P Bourne T Forman A Hormone replacement therapy after transcervical resection of the endometrium Proceedings of the 8th International Congress on the Menopause, 1996, Nov 3-7 Sidney, Australia 1996 100","DOI":"10.1016\/S0378-5122(97)81142-5"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0029-7844(96)00308-0","article-title":"Hormone replacement therapy after transcervical resection of the endometrium","volume":"88","author":"Istre","year":"1996","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0112|cit112","first-page":"75","article-title":"Bleeding patterns in menopausal women taking HRT","volume":"F-13-03","author":"Jaisamrarn","year":"2002","journal-title":"Climacteric"},{"issue":"9","key":"10.1002\/14651858.CD000402.pub4-BIB0113|cit113","first-page":"857","article-title":"Effect of combined oral estrogen\/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naive Thai women","volume":"82","author":"Jirapinyo","year":"2003","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/09513590400002318","article-title":"The comparison of bleeding patterns with high-dose and low-dose hormone replacement therapy in postmenopausal women","volume":"19","author":"Kazerooni","year":"2004","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0115|cit115","unstructured":"Von Holst TH Keil D Lang E Comparison of the incidence of irregular bleeding during treatment with a low dose continuous combined or sequential hormone replacement therapy The 1st scientific meeting of the Asia-Pacific Menopause Federation 2002 61"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0116|cit116","first-page":"407","article-title":"Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women","volume":"83","author":"Limpaphayom","year":"2000","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ajog.2004.12.067","article-title":"The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial","volume":"192","author":"Liu","year":"2005","journal-title":"American Journal of Obstetrics & Gynecololgy"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0118|cit118","first-page":"39","article-title":"Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy","volume":"71","author":"Luciano","year":"1988","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2362.1991.tb01416.x","article-title":"Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding","volume":"21","author":"Marslew","year":"1991","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0120|cit120","first-page":"202","article-title":"Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding","volume":"79","author":"Marslew","year":"1992","journal-title":"Obstetrics and Gynecology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD000402.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0002-9378(91)90677-J","article-title":"Bleeding patterns during continuous combined estrogen-progestogen therapy","volume":"164","author":"Marslew","year":"1991","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5122(97)01110-9","article-title":"Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen\/progestin therapy: a 2-year prospective study","volume":"27","author":"Mizunuma","year":"1997","journal-title":"Maturitas"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.GME.0000109314.11228.E5","article-title":"Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study","volume":"11","author":"Crisafulli","year":"2004","journal-title":"Menopause"},{"issue":"10","key":"10.1002\/14651858.CD000402.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1359\/jbmr.2002.17.10.1904","article-title":"Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study","volume":"17","author":"Morabito","year":"2002","journal-title":"Journal of Bone & Mineral Research"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00006250-197907000-00017","article-title":"Estrogen replacement therapy II: A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems","volume":"54","author":"Nachtigall","year":"1979","journal-title":"Obstetrics and Gynecology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000402.pub4-BIB0126|cit126","first-page":"128","article-title":"Bleeding patterns in postmenopausal women using two types of continuous combined hormone replacement therapy","volume":"14","author":"Odmark","year":"2000","journal-title":"Gynecological Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1067\/mob.2001.112561","article-title":"Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17B-estradiol and norethindrone acetate","volume":"184","author":"Odmark","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000402.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0015-0282(03)01849-1","article-title":"Impact of conjugated estrogens (CE)\/trimegestone (TMG) on endometrial hyperplasia and bleeding profiles in a double-blind, randomized, placebo-controlled study","volume":"80","author":"Pickar","year":"2003","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1067\/mob.2003.335","article-title":"Effects of trimonthly progestin administration on the endometrium in elderly postmenopausal women who receive hormone replacement therapy: a pilot study","volume":"189","author":"Pinto","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.maturitas.2005.04.004","article-title":"Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy","volume":"53","author":"Popp","year":"2006","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0015-0282(16)45981-9","article-title":"Endometrial hyperplasia in women on cyclic or continuous estrogen regimens","volume":"37","author":"Schiff","year":"1982","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00042192-200109000-00005","article-title":"Unscheduled bleeding during initiation of continuous combined hormone replacement therapy:a direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogens","volume":"8","author":"Simon","year":"2001","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1067\/mob.2003.104","article-title":"Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy","volume":"188","author":"Simon","year":"2003","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.AOG.0000251518.56369.eb","article-title":"Unopposed estradiol therapy in postmenopausal women: results from two randomized trials","volume":"109","author":"Steiner","year":"2007","journal-title":"Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-5122(00)00219-X","article-title":"17beta-Estradiol (1 mg\/day) continuously combined with dydrogesterone (5, 10 or 20 mg\/day) increases bone mineral density in postmenopausal women","volume":"38","author":"Stevenson","year":"2001","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0136|cit136","doi-asserted-by":"crossref","unstructured":"Stevenson Jc DGKEPT Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17[beta]-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study Maturitas 2010 227 32","DOI":"10.1016\/j.maturitas.2010.07.002"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0137|cit137","doi-asserted-by":"crossref","unstructured":"Sturdee DW Bleeding patterns and endometrial histology with sequential HRT Proceedings of the 8th International Congress on the Menopause, 1996, Nov 3-7 Sidney, Australia 1996 S36","DOI":"10.1016\/S0378-5122(97)80937-1"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1471-0528.2000.tb11654.x","article-title":"The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy","volume":"11","author":"Sturdee","year":"2000","journal-title":"British Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0139|cit139","doi-asserted-by":"crossref","unstructured":"Sturdee DW ADFRVLECSI Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women Climacteric : the journal of the International Menopause Society 2008 63 73","DOI":"10.1080\/13697130701852390"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0140|cit140","first-page":"366","article-title":"Vaginal bleeding in postmenopausal women taking low dose norethindrone acetate and ethinyl estradiol combinations","volume":"96","author":"Symons","year":"2000","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0141|cit141","first-page":"84","article-title":"Comparative effect of norethindrone acetate\/ethinyl estradiol and 0.625 mg conjugated estrogen\/2.5 mg medroxyprogesterone acetate on bleeding control: early results from a randomized placebo controlled trial.","volume":"Suppl","author":"Symons","year":"2002","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0142|cit142","first-page":"146","article-title":"Bleeding control, endometrial safety and adherence to continuous combined HRT after 5 years","volume":"P-07-21","author":"Ulla Timonen","year":"2002","journal-title":"Climacteric"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD000402.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/S0015-0282(02)03812-8","article-title":"Efficacy and safety study of a new synthetic 10-component, modified release conjugated estrogens (CE) tablet for treatment of vasomotor symptoms in postmenopausal women","volume":"78","author":"Utian","year":"2002","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0144|cit144","doi-asserted-by":"crossref","unstructured":"van der Mooren MJ Hanselaar A Schiff Ch PT Girardin C Sequential three-monthly versus monthly HRT: a prospective double-blind randomised study Proceedings of the 8th International Congress on the Menopause, 1996, Nov 3-7 Sidney, Australia 1996 47","DOI":"10.1016\/S0378-5122(97)80977-2"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000402.pub4-BIB0145|cit145","first-page":"210","article-title":"Long-term data on endometrial safety and bleeding control with a continuous combined HRT regimen","volume":"5","author":"Weijer","year":"2002","journal-title":"Climacteric. 10th World Congress on Menopause"},{"issue":"8","key":"10.1002\/14651858.CD000402.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6874-8-5","article-title":"Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial","volume":"26","author":"Veerus","year":"2008","journal-title":"BMC Women's Health"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0378-5122(86)90040-X","article-title":"Benefits and risks of different hormonal replacement therapies in post-menopausal women","volume":"6","author":"Volpe","year":"1986","journal-title":"Maturitas"},{"issue":"4","key":"10.1002\/14651858.CD000402.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0378-5122(02)00203-7","article-title":"Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone","volume":"43","author":"Holst","year":"2002","journal-title":"Maturitas"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/humrep\/17.5.1386","article-title":"The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study","volume":"17","author":"Wahab","year":"2002","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0150|cit150","first-page":"256","article-title":"Profiles of irregular bleeding induced by low-dose hormone therapy and Chinese formulated herb products","volume":"28","author":"Wang","year":"2006","journal-title":"Acta Academiae Medicinae Sinicae"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.GME.0000097846.95550.AA","article-title":"Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women","volume":"11","author":"Warming","year":"2004","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0152|cit152","doi-asserted-by":"crossref","unstructured":"Webster M Combination continuous therapy - what is the optimal MPA dose? Effect on bleeding profiles and endometrial histology Proceedings of the 8th International Congress on the Menopause, 1996, Nov 3-7 Sidney, Australia 1996 27","DOI":"10.1016\/S0378-5122(97)80918-8"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0002-9378(90)90917-V","article-title":"Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient","volume":"162","author":"Weinstein","year":"1990","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.325.7358.239","article-title":"Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study","volume":"325","author":"Wells","year":"2002","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0002-9378(90)90402-S","article-title":"A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement","volume":"162","author":"Williams","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0156|cit156","first-page":"23","article-title":"Effects of period free hormone replacement therapy in postmenopausal women in Taiwan","volume":"65","author":"Yang","year":"2001","journal-title":"Chinese Medical Journal (Taipei)"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0157|cit157","first-page":"14","article-title":"Estrogens; conjugated and esterified therapeutic substitution","volume":"19","author":"Ansbacher","year":"1994","journal-title":"Female Pat"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM197901043000103","article-title":"Endometrial cancer and estrogen use. Report of a large case-control study","volume":"300","author":"Antunes","year":"1979","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000402.pub4-BIB0159|cit159","first-page":"323","article-title":"Uterine bleeding in postmenopausal women on continuous therapy with oestradiol and norethindrone acetate","volume":"94","author":"Archer","year":"1999","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0160|cit160","doi-asserted-by":"crossref","unstructured":"Bachmann GA Schaefers M Uddin A Utian WH Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial Obstetrics & Gynecology 2007 771 9","DOI":"10.1097\/01.AOG.0000284450.51264.31"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00002018-199005050-00004","article-title":"A risk benefit assessment of oestrogen therapy in post menopausal women","volume":"5","author":"Cust","year":"1990","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/oxfordjournals.bmb.a072553","article-title":"HRT: Developments in therapy","volume":"48","author":"Ellerington","year":"1992","journal-title":"British Medical Bulletin"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0163|cit163","unstructured":"France J Personal communication July 1998"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0164|cit164","doi-asserted-by":"crossref","unstructured":"Freeman EW Sammel MD Lin H Liu Z Gracia CR Duration of menopausal hot flushes and associated risk factors Obstetrics & Gynecology 2011 1095 104","DOI":"10.1097\/AOG.0b013e318214f0de"},{"issue":"9","key":"10.1002\/14651858.CD000402.pub4-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"e1000335","DOI":"10.1371\/journal.pmed.1000335","article-title":"The haunting of medical journals: How ghostwriting sold \"HRT\"","volume":"7","author":"Fugh-Berman","year":"2010","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM197709152971102","article-title":"Oestrogen and endometrial carcinoma: an independent pathology review supporting original size estimate","volume":"297","author":"Gardan","year":"1977","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstetrics & Gynecology"},{"issue":"9483","key":"10.1002\/14651858.CD000402.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(05)66519-1","article-title":"Treatment of menopausal symptoms: what shall we do now?","volume":"366","author":"Hickey","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0170|cit170","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"10-1","key":"10.1002\/14651858.CD000402.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0039-128X(00)00119-7","article-title":"Nestorone: a progestin with a unique pharmacological profile","volume":"65","author":"Kumar","year":"2000","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behaviour of endometrial hyperplasia. A long term study of 'untreated' hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0173|cit173","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004861.pub2","article-title":"Types of progestogens in combined oral contraception: effectiveness and side-effects","author":"Lawrie","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1056\/NEJM197606032942304","article-title":"Estrogens and endometrial cancer in a retirement community","volume":"294","author":"Mack","year":"1976","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0175|cit175","unstructured":"MacLennan AH Personal communication"},{"issue":"7","key":"10.1002\/14651858.CD000402.pub4-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.7.872","article-title":"Postmenopausal hormone replacement therapy","volume":"288","author":"Nelson","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/13697139809085526","article-title":"A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II An assessment of treatment effects","volume":"1","author":"O'Connell","year":"1998","journal-title":"Climacteric"},{"issue":"1","key":"10.1002\/14651858.CD000402.pub4-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13697130400012288","article-title":"Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomised clinical trials","volume":"8","author":"Peeyananjarassri","year":"2005","journal-title":"Climacteric"},{"issue":"5","key":"10.1002\/14651858.CD000402.pub4-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0015-0282(03)01167-1","article-title":"Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results","volume":"80","author":"Pickar","year":"2003","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jnci\/89.15.1110","article-title":"Estrogen-progestin replacement therapy and endometrial cancer","volume":"89","author":"Pike","year":"1997","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0181|cit181","doi-asserted-by":"crossref","unstructured":"Politi MC Schleinitz MD Col NF Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis Journal of General Internal Medicine 2008 1507 13","DOI":"10.1007\/s11606-008-0655-4"},{"issue":"2","key":"10.1002\/14651858.CD000402.pub4-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1471-0528.2002.01167.x","article-title":"Intrauterine 10mug and 20mug levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: Clinical, endometrial and metabolic response","volume":"109","author":"Raudaskoski","year":"2002","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0183|cit183","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"7596","key":"10.1002\/14651858.CD000402.pub4-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/bmj.39153.522535.BE","article-title":"Managing the menopause","volume":"334","author":"Roberts","year":"2007","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJM197512042932302","article-title":"Association of exogenous oestrogen and endometrial carcinoma","volume":"293","author":"Smith","year":"1977","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0186|cit186","volume-title":"Clinical gynecologic endocrinology and infertility (7th edition)","author":"Speroff","year":"2005"},{"issue":"8928","key":"10.1002\/14651858.CD000402.pub4-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(94)91640-3","article-title":"Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestogen replacement therapy?","volume":"344","author":"Sturdee","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1447-0756.1997.tb00836.x","article-title":"The behaviour of endometrial hyperplasia: a prospective study","volume":"28","author":"Terakawa","year":"1997","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0029-7844(95)00115-8","article-title":"Combined continuous hormone replacement therapy: a clinical review","volume":"86","author":"Udoff","year":"1995","journal-title":"Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD000402.pub4-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"75","author":"Utian","year":"2001","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00016347709156348","article-title":"The effects of cyclical oestrogen therapy and sequential oestrogen therapy on the endometrium of postmenopausal women","volume":"65","author":"Whitehead","year":"1977","journal-title":"Acta Obstetrica et Gynecologica Scandinavica Supplement"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM198112313052701","article-title":"Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium","volume":"305","author":"Whitehead","year":"1981","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"13113","DOI":"10.1016\/0002-9378(87)90170-0","article-title":"Controversies concerning the safety of estrogen replacement therapy","volume":"156","author":"Whitehead","year":"1987","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"7644","key":"10.1002\/14651858.CD000402.pub4-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000402.pub4-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJM197512042932303","article-title":"Increased risk of endometrial carcinoma amongst users of conjugated oestrogens","volume":"293","author":"Ziel","year":"1975","journal-title":"New England Journal of Medicine"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000402.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000402.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T03:48:51Z","timestamp":1735703331000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000402.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":195,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000402.pub4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717954966.793462194","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,15]]}}}